AGS-004

N/A

Report date: 2024/01/02 20:03:52

Base Information

Drug NameAGS-004
Drug Alias NameAGS-004AGS-004001
ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine
Mechanisms of ActionCytotoxic T lymphocytes stimulants
TargetsNot applicable
Therapy Area/IndicationsHIV SeropositivityAcquired Immunodeficiency SyndromeHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMcgill - Queen'S University Press
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesResearch Institute Of The Mcgill University Health CentreArgos Therapeutics IncMcgill University Health Centre +[4] 
Active IndicationsN/A
Inactive IndicationsHIV SeropositivityAcquired Immunodeficiency SyndromeHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A